SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3/A - Registration statement under Securities Act of 1933: [Amend]
SEC Accession No. 0001104659-22-071059
Filing Date
2022-06-14
Accepted
2022-06-14 17:09:11
Documents
2

Document Format Files

Seq Description Document Type Size
1 S-3/A tm2217743-3_s3.htm S-3/A 67051
2 EXHIBIT 5.1 tm2217743d4_ex5-1.htm EX-5.1 26635
  Complete submission text file 0001104659-22-071059.txt   94787
Mailing Address 1201 ORANGE STREET SUITE 600 WILMINGTON DE 19801
Business Address 1201 ORANGE STREET SUITE 600 WILMINGTON DE 19801 484-254-6134
NRX Pharmaceuticals, Inc. (Filer) CIK: 0001719406 (see all company filings)

IRS No.: 822844431 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3/A | Act: 33 | File No.: 333-265492 | Film No.: 221015689
SIC: 2834 Pharmaceutical Preparations